Biotech Group Acquisition Corporation (BGAC)
Biotech Group Acquisition was planning to go public, but the IPO was withdrawn on Mar 26, 2024.
IPO Price
$10.00
Shares Offered
7,500,000
Deal Size
$75.00M
Company Description
Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (excluding China, Hong Kong and Macau).
Biotech Group Acquisition Corporation
Country | United States |
Founded | 2022 |
Industry | Shell Companies |
Sector | Financials |
CEO | Yiru (Melody) Shi |
Contact Details
Address: 2400 Barranca Pkwy, Suite 300 Irvine, CA 92606 United States | |
Phone | (949) 468-7078 |
Stock Details
Ticker Symbol | BGAC |
Exchange | NASDAQ |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0001916902 |
Employer ID | 88-0654269 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Yiru (Melody) Shi | Chief Executive Officer and Chairwoman |
Manu Ohri | Chief Financial Officer and Director Nominee |
Jingmin (Helen) Rogers | Director Nominee |
John Brugmann | Director Nominee |
Yi Wung | Director Nominee |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 26, 2024 | RW | Filing |
Jun 7, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Jul 22, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
May 26, 2022 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 15, 2022 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Mar 18, 2022 | DRS | [Cover] Draft Registration Statement |